TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,819,488 | -66.1% | 217,642 | +0.7% | 0.00% | -71.4% |
| Q2 2023 | $5,370,358 | +593.0% | 216,198 | +319.6% | 0.01% | +600.0% |
| Q1 2023 | $774,951 | +25.8% | 51,526 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $616,000 | +33.8% | 52,071 | -33.0% | 0.00% | 0.0% |
| Q3 2022 | $460,256 | +37.4% | 77,746 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $335,000 | -46.6% | 78,792 | +19.6% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | -34.2% | 65,894 | +31.4% | 0.00% | -50.0% |
| Q4 2021 | $953,000 | -81.7% | 50,141 | -67.9% | 0.00% | -80.0% |
| Q3 2021 | $5,196,000 | -19.3% | 156,153 | -5.9% | 0.01% | -16.7% |
| Q2 2021 | $6,435,000 | -22.6% | 165,887 | -3.9% | 0.01% | -29.4% |
| Q1 2021 | $8,315,000 | -15.6% | 172,534 | -8.9% | 0.02% | -15.0% |
| Q4 2020 | $9,852,000 | +756.7% | 189,384 | +340.7% | 0.02% | +566.7% |
| Q3 2020 | $1,150,000 | +76.4% | 42,976 | +28.5% | 0.00% | +50.0% |
| Q2 2020 | $652,000 | +54.1% | 33,457 | -22.1% | 0.00% | +100.0% |
| Q1 2020 | $423,000 | -8.8% | 42,956 | +2.8% | 0.00% | 0.0% |
| Q4 2019 | $464,000 | +182.9% | 41,790 | +43.2% | 0.00% | – |
| Q3 2019 | $164,000 | -35.2% | 29,193 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $253,000 | +18.8% | 29,193 | +10.1% | 0.00% | – |
| Q1 2019 | $213,000 | +95.4% | 26,519 | 0.0% | 0.00% | – |
| Q4 2018 | $109,000 | -17.4% | 26,519 | +12.5% | 0.00% | – |
| Q3 2018 | $132,000 | -57.4% | 23,571 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $310,000 | -3.1% | 23,571 | +4.7% | 0.00% | 0.0% |
| Q1 2018 | $320,000 | +73.0% | 22,521 | 0.0% | 0.00% | – |
| Q4 2017 | $185,000 | -30.7% | 22,521 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $267,000 | +18.1% | 22,521 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $226,000 | +20.9% | 22,521 | +40.2% | 0.00% | – |
| Q1 2017 | $187,000 | +171.0% | 16,058 | +8.0% | 0.00% | – |
| Q4 2016 | $69,000 | -40.0% | 14,870 | 0.0% | 0.00% | – |
| Q3 2016 | $115,000 | +27.8% | 14,870 | 0.0% | 0.00% | – |
| Q2 2016 | $90,000 | -29.1% | 14,870 | 0.0% | 0.00% | – |
| Q1 2016 | $127,000 | -28.2% | 14,870 | 0.0% | 0.00% | – |
| Q4 2015 | $177,000 | +18.0% | 14,870 | 0.0% | 0.00% | – |
| Q3 2015 | $150,000 | -53.7% | 14,870 | -23.9% | 0.00% | -100.0% |
| Q2 2015 | $324,000 | +6.9% | 19,552 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $303,000 | -2.3% | 19,552 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $310,000 | +48.3% | 19,552 | 0.0% | 0.00% | – |
| Q3 2014 | $209,000 | +13.6% | 19,552 | 0.0% | 0.00% | – |
| Q2 2014 | $184,000 | – | 19,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |